Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             115 results found
no title author magazine year volume issue page(s) type
1 A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo Gillespie, J.
 2008
 26 Supplement 3 p. 4231-4236
6 p.
 article
2 A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge Pretorius, A.
 2008
 26 Supplement 3 p. 4363-4371
9 p.
 article
3 Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines Verstraeten, Thomas
 2008
 26 Supplement 3 p. 6630-6638
9 p.
 article
4 An HSV-1 gD mutant virus as an entry-impaired live virus vaccine Awasthi, Sita
 2008
 26 Supplement 3 p. 1195-1203
9 p.
 article
5 Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3) Perelberg, Ayana
 2008
 26 Supplement 3 p. 3750-3756
7 p.
 article
6 An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results Schiller, John T.
 2008
 26 Supplement 3 p. K53-K61
nvt p.
 article
7 A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial Martin, Julie E.
 2008
 26 Supplement 3 p. 6338-6343
6 p.
 article
8 Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results Dhiman, Neelam
 2008
 26 Supplement 3 p. 1731-1736
6 p.
 article
9 Attenuated West Nile viruses bearing 3′SL and envelope gene substitution mutations Yu, Li
 2008
 26 Supplement 3 p. 5981-5988
8 p.
 article
10 Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination McKinley, Enid T.
 2008
 26 Supplement 3 p. 1274-1284
11 p.
 article
11 Bioneedles™ as vaccine carriers Hirschberg, Hoang J.H.B.
 2008
 26 Supplement 3 p. 2389-2397
9 p.
 article
12 c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection Ogunniyi, Abiodun D.
 2008
 26 Supplement 3 p. 4676-4685
10 p.
 article
13 Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects Guy, Bruno
 2008
 26 Supplement 3 p. 5712-5721
10 p.
 article
14 Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice Phumoonna, Tongted
 2008
 26 Supplement 3 p. 2457-2465
9 p.
 article
15 Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge Sánchez, Oliberto
 2008
 26 Supplement 3 p. 988-997
10 p.
 article
16 Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis Gates, A.E.
 2008
 26 Supplement 3 p. 2010-2019
10 p.
 article
17 Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children Givon-Lavi, Noga
 2008
 26 Supplement 3 p. 5798-5801
4 p.
 article
18 Comparison of epidemiologic methods for active surveillance of vaccine safety McClure, David L.
 2008
 26 Supplement 3 p. 3341-3345
5 p.
 article
19 Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs Hoshino, Yo
 2008
 26 Supplement 3 p. 4034-4040
7 p.
 article
20 Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants Gatchalian, Salvacion
 2008
 26 Supplement 3 p. 2234-2241
8 p.
 article
21 Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV Yang, Songtao
 2008
 26 Supplement 3 p. 1482-1487
6 p.
 article
22 Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum Xie, Yong
 2008
 26 Supplement 3 p. 3452-3460
9 p.
 article
23 Cost and cost-effectiveness of childhood vaccination against rotavirus in France Melliez, H.
 2008
 26 Supplement 3 p. 706-715
10 p.
 article
24 Cost-effectiveness of adult pertussis vaccination in Germany Lee, Grace M.
 2008
 26 Supplement 3 p. 3673-3679
7 p.
 article
25 Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073 Fytili, P.
 2008
 26 Supplement 3 p. 3818-3826
9 p.
 article
26 Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants Palma, Paolo
 2008
 26 Supplement 3 p. 5196-5201
6 p.
 article
27 Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4 Blaney Jr., Joseph E.
 2008
 26 Supplement 3 p. 817-828
12 p.
 article
28 Detecting AIDS restriction genes: From candidate genes to genome-wide association discovery Hutcheson, H.B.
 2008
 26 Supplement 3 p. 2951-2965
15 p.
 article
29 Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium Pohlscheidt, M.
 2008
 26 Supplement 3 p. 1552-1565
14 p.
 article
30 Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults Tang, Roderick S.
 2008
 26 Supplement 3 p. 6373-6382
10 p.
 article
31 DNA vaccine protects ornamental koi (Cyprinus carpio koi) against North American spring viremia of carp virus Emmenegger, E.J.
 2008
 26 Supplement 3 p. 6415-6421
7 p.
 article
32 Double-stranded RNA- and CpG DNA-induced immune responses in Atlantic salmon: Comparison and synergies Strandskog, Guro
 2008
 26 Supplement 3 p. 4704-4715
12 p.
 article
33 Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia Shefer, Abigail
 2008
 26 Supplement 3 p. K68-K75
nvt p.
 article
34 Editorial Board 2008
 26 Supplement 3 p. CO2-
1 p.
 article
35 Editorial Board 2008
 26 Supplement 3 p. CO2-
1 p.
 article
36 Editorial Board 2008
 26 Supplement 3 p. CO2-
1 p.
 article
37 Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway Vestrheim, Didrik F.
 2008
 26 Supplement 3 p. 3277-3281
5 p.
 article
38 Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden Spindler, Carl
 2008
 26 Supplement 3 p. 5541-5546
6 p.
 article
39 Efficacies of inactivated vaccines against betanodavirus in grouper larvae (Epinephelus coioides) by bath immunization Kai, Yu-Hsuan
 2008
 26 Supplement 3 p. 1450-1457
8 p.
 article
40 Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990–2006 Chang, Soju
 2008
 26 Supplement 3 p. 2428-2432
5 p.
 article
41 Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice Wei, Feng
 2008
 26 Supplement 3 p. 4145-4149
5 p.
 article
42 Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia Bosch, F. Xavier
 2008
 26 Supplement 3 p. K1-K16
nvt p.
 article
43 Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys Blaney Jr., Joseph E.
 2008
 26 Supplement 3 p. 4150-4159
10 p.
 article
44 Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women Kemp, Troy J.
 2008
 26 Supplement 3 p. 3608-3616
9 p.
 article
45 Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals Rizza, Paola
 2008
 26 Supplement 3 p. 1038-1049
12 p.
 article
46 Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals von Teichman, Beate F.
 2008
 26 Supplement 3 p. 5014-5021
8 p.
 article
47 Evaluation of widely consumed botanicals as immunological adjuvants Ragupathi, Govind
 2008
 26 Supplement 3 p. 4860-4865
6 p.
 article
48 First generation leishmaniasis vaccines: A review of field efficacy trials Noazin, Sassan
 2008
 26 Supplement 3 p. 6759-6767
9 p.
 article
49 Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife Geue, Lutz
 2008
 26 Supplement 3 p. 3227-3235
9 p.
 article
50 “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation Edelman, Robert
 2008
 26 Supplement 3 p. 4113-4119
7 p.
 article
51 HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: Implications for therapy and vaccine development Jacobs, Amy
 2008
 26 Supplement 3 p. 3026-3035
10 p.
 article
52 Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis Khan, Arif Azam
 2008
 26 Supplement 3 p. 316-332
17 p.
 article
53 Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy Valor, L.
 2008
 26 Supplement 3 p. 2738-2745
8 p.
 article
54 Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3 Gartner, Tatiana
 2008
 26 Supplement 3 p. 1458-1470
13 p.
 article
55 Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial Jiang, Wei-Ping
 2008
 26 Supplement 3 p. 2297-2301
5 p.
 article
56 Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population Leach, Amanda J.
 2008
 26 Supplement 3 p. 3885-3891
7 p.
 article
57 Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants Olivier, C.
 2008
 26 Supplement 3 p. 3142-3152
11 p.
 article
58 Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis West, Nicholas P.
 2008
 26 Supplement 3 p. 3853-3859
7 p.
 article
59 Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams Muñoz, Pilar-María
 2008
 26 Supplement 3 p. 2562-2569
8 p.
 article
60 Importance of the major Fli C antigenic site of Salmonella enteritidis as a subunit vaccine antigen Toyota-Hanatani, Yukiko
 2008
 26 Supplement 3 p. 4135-4137
3 p.
 article
61 Inactivated rotavirus vaccines: A priority for accelerated vaccine development Jiang, Baoming
 2008
 26 Supplement 3 p. 6754-6758
5 p.
 article
62 Influenza vaccine effectiveness and confounding factors among young children Fujieda, Megumi
 2008
 26 Supplement 3 p. 6481-6485
5 p.
 article
63 Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel Swartz, T.A.
 2008
 26 Supplement 3 p. 1083-1090
8 p.
 article
64 Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue Sabirov, Albert
 2008
 26 Supplement 3 p. 1566-1576
11 p.
 article
65 Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement Andrus, Jon Kim
 2008
 26 Supplement 3 p. K87-K92
nvt p.
 article
66 In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets Linghua, Zhang
 2008
 26 Supplement 3 p. 224-233
10 p.
 article
67 Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine Fei-fei, Ge
 2008
 26 Supplement 3 p. 5590-5594
5 p.
 article
68 Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers Littmann, Martina
 2008
 26 Supplement 3 p. 2344-2349
6 p.
 article
69 Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization Gudmundsdotter, Lindvi
 2008
 26 Supplement 3 p. 5107-5110
4 p.
 article
70 Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses Megati, Shakuntala
 2008
 26 Supplement 3 p. 5083-5094
12 p.
 article
71 Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures Jäkel, Anne
 2008
 26 Supplement 3 p. 6655-6663
9 p.
 article
72 Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates Fine, Donald L.
 2008
 26 Supplement 3 p. 3497-3506
10 p.
 article
73 Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A Taylor, Claribel P.
 2008
 26 Supplement 3 p. 3404-3409
6 p.
 article
74 Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2 Zhang, Hong-Ying
 2008
 26 Supplement 3 p. 769-777
9 p.
 article
75 Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies Zhang, Shoufeng
 2008
 26 Supplement 3 p. 345-350
6 p.
 article
76 Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries Cuzick, Jack
 2008
 26 Supplement 3 p. K29-K41
nvt p.
 article
77 Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research Kester, Kent E.
 2008
 26 Supplement 3 p. 2191-2202
12 p.
 article
78 Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers Sadorge, Christine
 2008
 26 Supplement 3 p. 978-987
10 p.
 article
79 Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage Erdem, Hakan
 2008
 26 Supplement 3 p. 1271-1273
3 p.
 article
80 Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs Manickam, R.
 2008
 26 Supplement 3 p. 6564-6568
5 p.
 article
81 Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data Bailleux, F.
 2008
 26 Supplement 3 p. 3903-3908
6 p.
 article
82 Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein Gorman, Shelley
 2008
 26 Supplement 3 p. 3860-3869
10 p.
 article
83 Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle Chang, Byoung Sun
 2008
 26 Supplement 3 p. 2081-2091
11 p.
 article
84 Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions Veits, Jutta
 2008
 26 Supplement 3 p. 1688-1696
9 p.
 article
85 Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 Hookworm Vaccine in unexposed adults Bethony, Jeffrey M.
 2008
 26 Supplement 3 p. 2408-2417
10 p.
 article
86 Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica Herrero, Rolando
 2008
 26 Supplement 3 p. 4795-4808
14 p.
 article
87 Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands David, Silke
 2008
 26 Supplement 3 p. 5883-5887
5 p.
 article
88 Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults Roukens, A.H.
 2008
 26 Supplement 3 p. 3438-3442
5 p.
 article
89 Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2 Kixmöller, Marion
 2008
 26 Supplement 3 p. 3443-3451
9 p.
 article
90 Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children Esteghamati, Abdoulreza
 2008
 26 Supplement 3 p. 5058-5061
4 p.
 article
91 Report of the third meeting on “Influenza vaccines that induce broad spectrum and long-lasting immune responses”, World Health Organization, Geneva, Switzerland, 3–4 December 2007 Girard, Marc P.
 2008
 26 Supplement 3 p. 2443-2450
8 p.
 article
92 Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice Hinkula, Jorma
 2008
 26 Supplement 3 p. 5101-5106
6 p.
 article
93 Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age Pietrzyk, Jacek J.
 2008
 26 Supplement 3 p. 5296-5303
8 p.
 article
94 Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants Li, Rong Cheng
 2008
 26 Supplement 3 p. 2260-2269
10 p.
 article
95 Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses Sigurdardottir, Sigurveig Th.
 2008
 26 Supplement 3 p. 4178-4186
9 p.
 article
96 Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China Zhu, Feng Cai
 2008
 26 Supplement 3 p. 4579-4584
6 p.
 article
97 Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial Sacarlal, Jahit
 2008
 26 Supplement 3 p. 174-184
11 p.
 article
98 Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines Prymula, Roman
 2008
 26 Supplement 3 p. 4563-4570
8 p.
 article
99 Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine Silva, Ana Carina
 2008
 26 Supplement 3 p. 3305-3311
7 p.
 article
100 Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections Zhan, Xiaoyan
 2008
 26 Supplement 3 p. 3480-3488
9 p.
 article
101 Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel Singer, Darrell E.
 2008
 26 Supplement 3 p. 869-873
5 p.
 article
102 Sexual dimorphism of humoral immunity with human vaccines Cook, Ian Francis
 2008
 26 Supplement 3 p. 3551-3555
5 p.
 article
103 Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age Block, Stan L.
 2008
 26 Supplement 3 p. 4940-4946
7 p.
 article
104 Strategies for financial sustainability of immunization programs: A review of the strategies from 50 national immunization program financial sustainability plans Kamara, Lidija
 2008
 26 Supplement 3 p. 6717-6726
10 p.
 article
105 Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine Lang, Krystle A.
 2008
 26 Supplement 3 p. 6225-6231
7 p.
 article
106 Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia Borkowsky, William
 2008
 26 Supplement 3 p. 3086-3089
4 p.
 article
107 TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area—Impact on current recommendations for immunization of high-risk groups Plíšek, Stanislav
 2008
 26 Supplement 3 p. 301-304
4 p.
 article
108 The antifertility effects of DNA vaccine-induced immune responses against uroguanylin Sun, Jing
 2008
 26 Supplement 3 p. 3696-3704
9 p.
 article
109 The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries Cook, Joseph
 2008
 26 Supplement 3 p. 6305-6316
12 p.
 article
110 The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex Fachinger, Vicky
 2008
 26 Supplement 3 p. 1488-1499
12 p.
 article
111 Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report But, David Yiu-Kuen
 2008
 26 Supplement 3 p. 6587-6591
5 p.
 article
112 Vaccination of cattle against tropical theileriosis in Uzbekistan using autochthonous live vaccine Rasulov, Ilhan
 2008
 26 Supplement 3 p. G14-G16
nvt p.
 article
113 Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers Vandepapelière, Pierre
 2008
 26 Supplement 3 p. 1375-1386
12 p.
 article
114 WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay Knezevic, I.
 2008
 26 Supplement 3 p. 3960-3968
9 p.
 article
115 Willingness of Chinese injection drug users to participate in HIV vaccine trials Yin, Lu
 2008
 26 Supplement 3 p. 762-768
7 p.
 article
                             115 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands